Altre lingue Humacyte, Inc.

Azioni

HUMA

US44486Q1031

Tempo reale stimato Cboe BZX Altri mercati azionari 17:01:56 30/04/2024			Variaz. 5gg	Var. 1 gen.
4,045 ^USD	-1,10%		+2,93%	+42,43%

28/03	Transcript : Humacyte, Inc. - Special Call
22/03	Transcript : Humacyte, Inc., Q4 2023 Earnings Call, Mar 22, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Humacyte to Host Virtual KOL Event Hemodialysis Access, a Crossroads of Care, on March 28, 2024	27/03
Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024	26/03
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update	25/03
Interest Rate, Monetary Policy Views Lift Wall Street Pre-Bell; Asia Mixed, Europe Up	22/03
Humacyte, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update	22/03
Humacyte, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024	18/03
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference	04/03
Humacyte Announces Proposed Public Offering of Common Stock	01/03
Sector Update: Health Care Stocks Edge Higher Premarket Friday	01/03
Investors Await Key Economic Data, Markets Remain Flat Ahead of Opening Bell	01/03
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference	01/03
Humacyte Prices $40.2 Million Share Offering	01/03
Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock	01/03
Humacyte, Inc. Announces Proposed Public Offering of Common Stock	29/02
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	09/02
Humacyte Shares Rise After FDA Grants Priority Review to Vascular Trauma Treatment	09/02
Sector Update: Health Care Stocks Mixed in Afternoon Trading	09/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Humacyte, Inc.

Azioni

HUMA

US44486Q1031

Altre lingue

Filtri